Global Point of Care
Risk factors for PC-AKI include chronic kidney disease, critical illness, contrast-enhanced imaging done as an emergency, older age, diabetes, use of nephrotoxic drugs and reduced kidney function.2
Contrast media can pose serious health risks to patients with chronic or acute renal insufficiency - including potentially fatal nephrogenic systemic fibrosis (NSF), a debilitating and potentially fatal disease that involves the skin, muscle and internal organs.1
Point-of-care (POC) creatinine devices allow rapid measurement of creatinine levels and calculation of estimated glomerular filtration rate (eGFR). This can show whether the kidneys are working properly.
Creatinine test results from the lab could take hours, disrupting the efficiency of the department or clinic and causing cancellation of some radiological procedures.
Contrast media can pose serious health risks to patients with chronic or acute renal insufficiency - including potentially fatal nephrogenic systemic fibrosis (NSF), a debilitating and potentially fatal disease that involves the skin, muscle and internal organs.1
Point-of-care (POC) creatinine devices allow rapid measurement of creatinine levels and calculation of estimated glomerular filtration rate (eGFR). This can show whether the kidneys are working properly.
Creatinine test results from the lab could take hours, disrupting the efficiency of the department or clinic and causing cancellation of some radiological procedures.
Risk factors for PC-AKI include chronic kidney disease, critical illness, contrast-enhanced imaging done as an emergency, older age, diabetes, use of nephrotoxic drugs and reduced kidney function.2
The i‑STAT Alinity, which calculates a patient's eGFR automatically, is recommended by the NICE Committee in the United Kingdom as one of the POC devices to assess kidney function.
The i‑STAT Alinity, which calculates a patient's eGFR
automatically, is recommended by the NICE Committee in the
United Kingdom as one of the POC devices to assess kidney
function.
The i‑STAT Alinity, which calculates a patient's eGFR
automatically, is recommended by the NICE Committee in the
United Kingdom as one of the POC devices to assess kidney
function.
Acute kidney injury (AKI) can occur rarely in patients exposed to iodinated contrast and result in contrast-induced AKI (Cl-AKI). A key risk factor is the presence of pre-existing chronic kidney disease (CKD); therefore, it is important to assess patient risk and obtain kidney function measurement prior to administration.3
Point-of-care testing for kidney function is an attractive method for providing a rapid result, particularly in the emergency department, acute medical unit or critical care setting where there is a need to make immediate decisions regarding treatment.4
Achieving up-to-date creatinine test results can be a major challenge for radiology departments. If recent results aren't available, procedures requiring contrast dye must be cancelled-often at the last minute.
With cancelled scans costing the hospital a minimum of £250, avoiding cancellations by having immediate creatinine test results can have a significant financial impact Learn how this major acute teaching hospital (that scans for more than 16,000 scheduled patients annually) tackled this probem through the adoption of point-of-care testing.
The i-STAT Alinity was built on the proven technology of the i-STAT 1 System, and is an easy-to-use, portable blood analyzer that delivers real-time, lab-quality diagnostic test results. The i-STAT Alinity's award-winning design features a more intuitive interface that simplifies the testing process even further, allowing for minimal operator training. i-STAT Alinity is the i-STAT family's most advanced testing solution.
A LEADER IN RAPID POINT-OF-CARE DIAGNOSTICS.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
